IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Berberine in breast cancer, a multi-targeted therapeutic agent from mechanisms to clinical translation
- Yang H. , et al.
2. Berberine as a Multifunctional Adjuvant in Cancer Therapy: Mechanistic Insights, Nanotechnological Strategies, and Translational Challenges
- Özalp Y. , et al.
4. Synergistic inhibitory effect of atmospheric pressure plasma and berberine on non‑small cell lung cancer cells via inducing apoptosis
- Ming H. , et al.
5. Coptidis rhizoma and berberine as anti-cancer drugs: A 10-year updates and future perspectives
- Chen G. , et al.
6. Estrogen receptor α36 in female estrogen-related tumors: regulatory mechanisms and targeted therapeutic advances
- Zhang L. , et al.
7. In Silico Investigation of Estrogen Receptor Alpha Inhibition by Alkyleneoxyberberine Derivatives
- Ngueanngam N. , et al.
8. Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments
- Sajeev A. , et al.
9. Expression Significance of Estrogen Receptor ER-α36 in Breast Cancer Treated by Chemotherapy: A Meta-Analysis
- He E. , et al.
10. Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights
- Sharma P. , et al.
11. Integrating Chinese medicine into mainstream cancer therapies: a promising future
- Ni B. , et al.
12. RECENT STUDIES ON BERBERINE AND ITS BIOLOGICAL AND PHARMACOLOGICAL ACTIVITIES
- Nadalin P. , et al.